ArticleWiener klinische Wochenschrift2026
Single odor identification in subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Article in Wiener klinische Wochenschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlfactory dysfunction is an early biomarker of Alzheimer's dementia (AD) and cognitive impairments. This study examines odor-specific olfactory deficits across cognitive impairment stages using the Sniffin' Sticks Odor Identification Test (SS-OIT).
objectiveTo assess the discriminative validity of specific odors in differentiating subjective cognitive decline (SCD), non-amnestic mild cognitive impairment (naMCI), amnestic mild cognitive impairment (aMCI), and AD from healthy controls (HC). Additionally, the influences of age, gender, verbal intelligence and depression on olfactory performance were analyzed. Participants were also grouped into an AD versus non-AD category (comprising SCD, naMCI, and aMCI) for logistic regression analyses.
methodsA retrospective analysis at the Department of Neurology of the Medical University of Vienna included 737 participants aged 50 years and older. Olfactory identification was assessed using the 16-item Sniffin' Sticks odor identification test. The discriminative power of specific odors was evaluated for distinguishing AD from non-AD groups. Bonferroni corrections were applied to adjust for multiple comparisons, which increases the stringency of statistical significance across the 16 odors tested.
resultsSignificant differences in odor identification were observed across diagnostic groups. The AD patients exhibited the most pronounced deficits, particularly in recognizing clove, rose and aniseed. Age negatively correlated with olfactory performance, while higher verbal intelligence was a protective factor. Key odors differentiated AD from non-AD groups, highlighting the diagnostic potential of olfactory testing.
conclusionOdor-specific olfactory deficits serve as early indicators of cognitive decline. The Sniffin' Sticks test, particularly key odors, may aid early detection and differentiation of cognitive impairments. Accounting for covariates enhances the diagnostic accuracy. Future research should aim to refine olfactory testing protocols and assess their clinical utility in broader populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.